Search company, investor...

Predict your next investment

Angel Investor (Group)
bostonharborangels.com

Investments

152

Portfolio Exits

14

Partners & Customers

1

About Boston Harbor Angels

Boston Harbor Angels is a group of business leaders interested in investing in growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc. The group's focus is on early stage companies usually looking to raise $250K to $1.5M, where Boston Harbor can fund a portion of the round and then syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. The firm looks for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.

Headquarters Location

Boston, Massachusetts,

United States

Want to inform investors similar to Boston Harbor Angels about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Boston Harbor Angels News

11:30 ET Boston Harbor Angels to Expand to Miami

Jan 24, 2022

News provided by Share this article Share this article BOSTON, Jan. 24, 2022 /PRNewswire/ -- Boston Harbor Angels, Inc (BHA), a leading Boston-based angel investment group, announced today that it is opening a Miami presence of BHA. Ziad Moukheiber, President and CEO of BHA said, "We are very excited to have a presence in Miami and to collaborate with local investors and entrepreneurs to continue the BHA brand of investing for a better world." Boston Harbor Angels to Expand to Miami Boston Harbor Angels Expands to Miami BHA will extend its long and fruitful collaboration with Babson College to Babson's Miami campus in Brickell. BHA members, many of whom spend time in Florida and Miami in particular, are also looking forward to extending BHA's activities in sunny Florida. "We are looking forward to having Boston Harbor Angels at our campus in Brickell," said Gustavo Trindade, Director Babson College Miami. "We are eager to host Boston Harbor Angels and to collaborate in helping to fund our entrepreneurs. I have attended BHA meetings in Boston at Babson's Wellesley campus and the impact they have on the entrepreneurship community is something we are looking forward to extending to Miami." About Boston Harbor Angels Boston Harbor Angels, like a lighthouse, helps entrepreneurs navigate and grow their start-up businesses through the treacherous waters of an increasingly competitive environment in our global economy. Boston Harbor Angels is a group of proven business leaders interested in investing a portion of our assets in high-growth, early-stage companies. Since 2004 we have made investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation, etc. We believe we contribute more than money to the companies we fund and welcome the opportunity to work with entrepreneurs who are open to taking advice yet have the smarts and determination to make their company successful. Contact Information:

Boston Harbor Angels Investments

152 Investments

Boston Harbor Angels has made 152 investments. Their latest investment was in S'More as part of their Seed VC - II on January 1, 2021.

CBI Logo

Boston Harbor Angels Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

1/26/2021

Seed VC - II

S'More

$2.1M

Yes

14

12/10/2020

Series A

Astrocyte Pharmaceuticals

$6M

No

2

9/26/2017

Series B - II

BIOARRAY Genetics

$4M

No

6

3/24/2017

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

4/29/2015

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

1/26/2021

12/10/2020

9/26/2017

3/24/2017

4/29/2015

Round

Seed VC - II

Series A

Series B - II

Seed VC

Series A

Company

S'More

Astrocyte Pharmaceuticals

BIOARRAY Genetics

Subscribe to see more

Subscribe to see more

Amount

$2.1M

$6M

$4M

$99M

$99M

New?

Yes

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

14

2

6

10

10

Boston Harbor Angels Portfolio Exits

14 Portfolio Exits

Boston Harbor Angels has 14 portfolio exits. Their latest portfolio exit was Respiratory Motion on June 01, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

6/1/2022

Acquired

$99M

3

2/4/2021

Acquired

$99M

4

8/26/2019

Acquired

$99M

3

8/21/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

6/12/2017

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/1/2022

2/4/2021

8/26/2019

8/21/2019

6/12/2017

Exit

Acquired

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Sources

3

4

3

10

10

Boston Harbor Angels Partners & Customers

1 Partners and customers

Boston Harbor Angels has 1 strategic partners and customers. Boston Harbor Angels recently partnered with Boehringer Ingelheim, and Abexxa Biologics on December 12, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

12/13/2017

Partner

Germany, and United States

Boehringer Ingelheim highlights progress of immuno-oncology collaborations – Boston Harbor Angels

It has also partnered with Siamab Therapeutics to identify anticancer therapeutics that target tumour-associated carbohydrate antigens , while another collaboration with AbeXXa Biologics has been formed to identify new selective molecular targets for cancer from the thousands of proteins found inside tumour cells .

1

Date

12/13/2017

Type

Partner

Business Partner

Country

Germany, and United States

News Snippet

Boehringer Ingelheim highlights progress of immuno-oncology collaborations – Boston Harbor Angels

It has also partnered with Siamab Therapeutics to identify anticancer therapeutics that target tumour-associated carbohydrate antigens , while another collaboration with AbeXXa Biologics has been formed to identify new selective molecular targets for cancer from the thousands of proteins found inside tumour cells .

Sources

1

Boston Harbor Angels Team

2 Team Members

Boston Harbor Angels has 2 team members, including current Managing Director, Boris Batchvarov.

Name

Work History

Title

Status

Boris Batchvarov

Managing Director

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Boris Batchvarov

Subscribe to see more

Work History

Title

Managing Director

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.